IQVIA Holdings Inc.

NYSE:IQV

Medical - Diagnostics & Research

Healthcare
$257.84 -1.83%

-$3.13 today

Market cap
$42.49B
Beta
1.22
P/E (TTM)
20.4
EPS (TTM)
$8.22
52W Low $153.01High $247.05

Volume 1.40M

Average 1.62M

IQV Long-term Debt

Borrowings due after more than one year.

IQVIA Holdings Inc.NYSE: IQV

Long-term Debt · Q2 FY2026 · quarter ended Jun 2026

Long-term debt falls 3.3% from a year ago

Long-term debt stood at $13.71B at the end of Q2 FY2026, down 3.3% from a year earlier and down 2.0% from the prior quarter. Over 3 fiscal years it compounded at +3.9% a year.

Context

  • Long-term debt amounted to 45.9% of total assets at the end of Q2 FY2026, down 3.6 pp from a year earlier.
  • Long-term debt increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether long-term debt keeps falling in the next quarterly balance sheet after a -3.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$13.71B-2.0% QoQ
Last fiscal yearDec 2025
$14.11B+9.9% YoY
Year agoJun 2025
$14.18B-3.3% since
Long-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.3%——
1 year+9.9%——
3-year CAGR+3.9%——
5-year CAGR——
10-year CAGR——

Long-term Debt history

USD · from the balance sheet

Latest · FY2025
14.11B USD
Year-over-year change
+9.9%
4-year CAGR
+4.1%

Long-term Debt vs competitors

How IQV compares with its peers on the latest reported figures

  • IQV's Jun 2026 long-term debt of $13.71B is the highest of the 9 companies compared; the peer median is $663.35M.
  • Its year-over-year change of -3.3% is the 5th highest of 7, against a peer median of -0.4%.
  • Long-term debt amounts to 45.9% of total assets for IQV, versus a peer median of 27.0%.
IQV Competitors Peer median
Long-term Debt for IQV and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IQVIQVIA Holdings Inc.Jun 2026$13.71B -3.3%+3.9%45.9%
CRLCharles River Laboratories International, Inc.Jun 2026$2.62B +12.3%-2.0%34.8%
ICLRICON Public Limited CompanyJun 2026$2.11B -37.6%-14.5%12.9%
TEMTempus AI, Inc.Sep 2026$1.24B -0.1%+47.1%50.8%
FTREFortrea Holdings Inc.Jun 2026$1.04B -5.8%—38.2%
CERTCertara, Inc.Mar 2026$289.5M -0.8%-69.2%19.3%
HCATHealth Catalyst, Inc.Mar 2026$151.74M +0.3%-12.5%36.8%
VEEVVeeva Systems Inc.Jul 2026$0 ——0.0%
MEDPMedpace Holdings, Inc.Sep 2026$0 ——0.0%
Peer median (excluding IQV) $663.35M-0.4%-12.5%27.0%

Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.37B1.22B1.38B1.7B1.98B
Short-term Investments111M93M120M141M161M
Net Receivables2.61B2.96B3.41B3.24B3.43B
Inventory00000
Other Current Assets521M561M546M592M519M
Total Current Assets4.76B4.98B5.6B5.83B6.25B
Property, Plant & Equipment (Net)903M863M819M773M823M
Goodwill13.3B13.92B14.57B14.71B16.62B
Intangible Assets4.94B4.82B4.84B4.5B4.96B
Long-term Investments164M162M239M374M432M
Tax Assets124M118M166M194M357M
Other Non-current Assets491M472M455M520M505M
Total Non-current Assets19.93B20.36B21.09B21.07B23.7B
Total Assets24.69B25.34B26.68B26.9B29.94B
Account Payables621M645M709M736M3.75B
Short-term Debt91M152M718M1.15B1.84B
Tax Payables137M161M116M156M0
Deferred Revenue1.83B1.8B1.8B1.78B2.12B
Other Current Liabilities1.15B1.13B1.26B1.1B489M
Total Current Liabilities5.24B5.58B6.49B6.96B8.34B
Long-term Debt12.03B12.6B12.96B12.84B14.11B
Deferred Tax Liabilities410M464M202M196M179M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities649M671M698M668M463M
Total Non-current Liabilities13.41B13.99B14.08B13.88B14.98B
Total Liabilities18.65B19.57B20.57B20.83B23.31B
Common Stock3M10.9B3M3M11.38B
Retained Earnings2.24B3.33B4.69B6.07B7.43B
Accumulated OCI(406M)(727M)(867M)(1.04B)(943M)
Other Stockholders Equity0(10.9B)000
Minority Interest0000127M
Total Equity6.04B5.77B6.11B6.07B6.63B
Total Debt12.44B13.01B13.9B14.16B16.17B
Net Debt11.07B11.8B12.52B12.45B14.19B

IQVIA Holdings Inc.

NYSE:IQV

Intrinsic Alpha fair value

Locked

Current Price

$257.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.